-
1
-
-
0037126729
-
Evaluation, and Treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report
-
National Cholesterol Education Program (NCEP) Expert Panel on Detection
-
National Cholesterol Education Program (NCEP) Expert Panel on Detection. Evaluation, and Treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 106 (2002) 3143-3421
-
(2002)
Circulation
, vol.106
, pp. 3143-3421
-
-
-
2
-
-
3142729178
-
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines
-
Grundy S.M., Cleeman J.I., Merz C.N., Brewer Jr. H.B., Clark L.T., Hunninghake D.B., Pasternak R.C., Smith Jr. S.C., and Stone N.J. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110 (2004) 227-239
-
(2004)
Circulation
, vol.110
, pp. 227-239
-
-
Grundy, S.M.1
Cleeman, J.I.2
Merz, C.N.3
Brewer Jr., H.B.4
Clark, L.T.5
Hunninghake, D.B.6
Pasternak, R.C.7
Smith Jr., S.C.8
Stone, N.J.9
-
3
-
-
44649098307
-
Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology foundation
-
Brunzell J.D., Davidson M., Furberg C.D., Goldberg R.B., Howard B.V., Stein J.H., and Witztum J.L. Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology foundation. Diab Care 31 (2008) 811-822
-
(2008)
Diab Care
, vol.31
, pp. 811-822
-
-
Brunzell, J.D.1
Davidson, M.2
Furberg, C.D.3
Goldberg, R.B.4
Howard, B.V.5
Stein, J.H.6
Witztum, J.L.7
-
4
-
-
0037069339
-
Low-density lipoprotein, non-high-density lipoprotein, and apolipoprotein B as targets of lipid-lowering therapy
-
Grundy S.M. Low-density lipoprotein, non-high-density lipoprotein, and apolipoprotein B as targets of lipid-lowering therapy. Circulation 106 (2002) 2526-2529
-
(2002)
Circulation
, vol.106
, pp. 2526-2529
-
-
Grundy, S.M.1
-
5
-
-
0842285784
-
Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management
-
Grundy S.M., Hansen B., Smith Jr. S.C., Cleeman J.I., and Kahn R.A. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation 109 (2004) 551-556
-
(2004)
Circulation
, vol.109
, pp. 551-556
-
-
Grundy, S.M.1
Hansen, B.2
Smith Jr., S.C.3
Cleeman, J.I.4
Kahn, R.A.5
-
6
-
-
35048827381
-
Relationship of apolipoprotein B levels to the number of risk factors for metabolic syndrome
-
Clarenbach J.J., Grundy S.M., Palacio N., and Vega G.L. Relationship of apolipoprotein B levels to the number of risk factors for metabolic syndrome. J Invest Med 55 (2007) 237-247
-
(2007)
J Invest Med
, vol.55
, pp. 237-247
-
-
Clarenbach, J.J.1
Grundy, S.M.2
Palacio, N.3
Vega, G.L.4
-
7
-
-
27444443876
-
Diagnosis and management of the metabolic syndrome-an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
-
Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., Gordon D.J., Krauss R.M., Savage P.J., Smith S.C., Spertus J.A., and Costa F. Diagnosis and management of the metabolic syndrome-an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112 (2005) 2735-2752
-
(2005)
Circulation
, vol.112
, pp. 2735-2752
-
-
Grundy, S.M.1
Cleeman, J.I.2
Daniels, S.R.3
Donato, K.A.4
Eckel, R.H.5
Franklin, B.A.6
Gordon, D.J.7
Krauss, R.M.8
Savage, P.J.9
Smith, S.C.10
Spertus, J.A.11
Costa, F.12
-
8
-
-
0242490858
-
Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update
-
Genest J., Frohlich J., Fodor G., and McPherson R. Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update. Can Med Assoc J 169 (2003) 921-924
-
(2003)
Can Med Assoc J
, vol.169
, pp. 921-924
-
-
Genest, J.1
Frohlich, J.2
Fodor, G.3
McPherson, R.4
-
9
-
-
23044485065
-
Joint distribution of non-HDL and LDL cholesterol and coronary heart disease risk prediction among individuals with and without diabetes
-
Liu J., Sempos C., Donahue R.P., Dorn J., Trevisan M., and Grundy S.M. Joint distribution of non-HDL and LDL cholesterol and coronary heart disease risk prediction among individuals with and without diabetes. Diab Care 28 (2005) 1916-1921
-
(2005)
Diab Care
, vol.28
, pp. 1916-1921
-
-
Liu, J.1
Sempos, C.2
Donahue, R.P.3
Dorn, J.4
Trevisan, M.5
Grundy, S.M.6
-
10
-
-
27744452965
-
Non-high-density lipoprotein cholesterol: the forgotten therapeutic target
-
Maki K.C., Galant R., and Davidson M.H. Non-high-density lipoprotein cholesterol: the forgotten therapeutic target. Am J Cardiol 96 (2005) 59K-64K
-
(2005)
Am J Cardiol
, vol.96
-
-
Maki, K.C.1
Galant, R.2
Davidson, M.H.3
-
11
-
-
46449096115
-
Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment
-
Kastelein J.J., van der Steeg W.A., Holme I., Gaffney M., Cater N.B., Barter P., Deedwania P., Olsson A.G., Boekholdt S.M., Demicco D.A., Szarek M., Larosa J.C., Pedersen T.R., and Grundy S.M. Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment. Circulation 117 (2008) 3002-3009
-
(2008)
Circulation
, vol.117
, pp. 3002-3009
-
-
Kastelein, J.J.1
van der Steeg, W.A.2
Holme, I.3
Gaffney, M.4
Cater, N.B.5
Barter, P.6
Deedwania, P.7
Olsson, A.G.8
Boekholdt, S.M.9
Demicco, D.A.10
Szarek, M.11
Larosa, J.C.12
Pedersen, T.R.13
Grundy, S.M.14
-
12
-
-
3042743500
-
Non-HDL cholesterol as a measure of atherosclerotic risk
-
Packard C.J., and Saito Y. Non-HDL cholesterol as a measure of atherosclerotic risk. J Atheroscler Thromb 11 (2004) 6-14
-
(2004)
J Atheroscler Thromb
, vol.11
, pp. 6-14
-
-
Packard, C.J.1
Saito, Y.2
-
13
-
-
33645096052
-
ApoB versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel
-
Barter P.J., Ballantyne C.M., Carmena R., Castro Cabezas M., Chapman M.J., Couture P., de Graaf J., Durrington P.N., Faergeman O., Frohlich J., Furberg C.D., Gagne C., Haffner S.M., Humphries S.E., Jungner I., Krauss R.M., Kwiterovich P., Marcovina S., Packard C.J., Pearson T.A., Reddy K.S., Rosenson R., Sarrafzadegan N., Sniderman A.D., Stalenhoef A.F., Stein E., Talmud P.J., Tonkin A.M., Walldius G., and Williams K.M. ApoB versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel. J Intern Med 259 (2006) 247-258
-
(2006)
J Intern Med
, vol.259
, pp. 247-258
-
-
Barter, P.J.1
Ballantyne, C.M.2
Carmena, R.3
Castro Cabezas, M.4
Chapman, M.J.5
Couture, P.6
de Graaf, J.7
Durrington, P.N.8
Faergeman, O.9
Frohlich, J.10
Furberg, C.D.11
Gagne, C.12
Haffner, S.M.13
Humphries, S.E.14
Jungner, I.15
Krauss, R.M.16
Kwiterovich, P.17
Marcovina, S.18
Packard, C.J.19
Pearson, T.A.20
Reddy, K.S.21
Rosenson, R.22
Sarrafzadegan, N.23
Sniderman, A.D.24
Stalenhoef, A.F.25
Stein, E.26
Talmud, P.J.27
Tonkin, A.M.28
Walldius, G.29
Williams, K.M.30
more..
-
14
-
-
0037333159
-
Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment
-
Sniderman A.D., Furberg C.D., Keech A., Roeters van Lennep J.E., Frohlich J., Jungner I., and Walldius G. Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment. Lancet 361 (2003) 777-780
-
(2003)
Lancet
, vol.361
, pp. 777-780
-
-
Sniderman, A.D.1
Furberg, C.D.2
Keech, A.3
Roeters van Lennep, J.E.4
Frohlich, J.5
Jungner, I.6
Walldius, G.7
-
15
-
-
27744444803
-
Assessment of reaching goal in patients with combined hyperlipidemia: low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, or apolipoprotein B
-
Stein E.A., Sniderman A., and Laskarzewski P. Assessment of reaching goal in patients with combined hyperlipidemia: low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, or apolipoprotein B. Am J Cardiol 96 (2005) 36K-43K
-
(2005)
Am J Cardiol
, vol.96
-
-
Stein, E.A.1
Sniderman, A.2
Laskarzewski, P.3
-
16
-
-
0038402528
-
Concordance/discordance between plasma apolipoprotein B levels and the cholesterol indexes of atherosclerotic risk
-
Sniderman A.D., Pierre A.C., Cantin B., Dagenais G.R., Despres J.P., and Lamarche B. Concordance/discordance between plasma apolipoprotein B levels and the cholesterol indexes of atherosclerotic risk. Am J Cardiol 91 (2003) 1173-1177
-
(2003)
Am J Cardiol
, vol.91
, pp. 1173-1177
-
-
Sniderman, A.D.1
Pierre, A.C.2
Cantin, B.3
Dagenais, G.R.4
Despres, J.P.5
Lamarche, B.6
-
17
-
-
33644873843
-
Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men
-
Pischon T., Girman C.J., Sacks F.M., Rifai N., Stampfer M.J., and Rimm E.B. Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men. Circulation 112 (2005) 3375-3383
-
(2005)
Circulation
, vol.112
, pp. 3375-3383
-
-
Pischon, T.1
Girman, C.J.2
Sacks, F.M.3
Rifai, N.4
Stampfer, M.J.5
Rimm, E.B.6
-
18
-
-
14944342962
-
Differences between markers of atherogenic lipoproteins in predicting high cardiovascular risk and subclinical atherosclerosis in asymptomatic men
-
Simon A., Chironi G., Gariepy J., Del Pino M., and Levenson J. Differences between markers of atherogenic lipoproteins in predicting high cardiovascular risk and subclinical atherosclerosis in asymptomatic men. Atherosclerosis 179 (2005) 339-344
-
(2005)
Atherosclerosis
, vol.179
, pp. 339-344
-
-
Simon, A.1
Chironi, G.2
Gariepy, J.3
Del Pino, M.4
Levenson, J.5
-
19
-
-
0035423181
-
Correlation of non-high-density lipoprotein cholesterol with apolipoprotein B: effect of 5 hydroxymethylglutaryl coenzyme A reductase inhibitors on non-high-density lipoprotein cholesterol levels
-
Ballantyne C.M., Andrews T.C., Hsia J.A., Kramer J.H., and Shear C. Correlation of non-high-density lipoprotein cholesterol with apolipoprotein B: effect of 5 hydroxymethylglutaryl coenzyme A reductase inhibitors on non-high-density lipoprotein cholesterol levels. Am J Cardiol 88 (2001) 265-269
-
(2001)
Am J Cardiol
, vol.88
, pp. 265-269
-
-
Ballantyne, C.M.1
Andrews, T.C.2
Hsia, J.A.3
Kramer, J.H.4
Shear, C.5
-
20
-
-
48849112223
-
Statin therapy alters the relationship between apolipoprotein B and low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol targets in high-risk patients-the MERCURY II (Measuring Effective Reductions in Cholesterol Using Rosuvastatin therapY II) trial
-
Ballantyne C.M., Raichlen J.S., and Cain V.A. Statin therapy alters the relationship between apolipoprotein B and low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol targets in high-risk patients-the MERCURY II (Measuring Effective Reductions in Cholesterol Using Rosuvastatin therapY II) trial. J Am Coll Cardiol 52 (2008) 626-632
-
(2008)
J Am Coll Cardiol
, vol.52
, pp. 626-632
-
-
Ballantyne, C.M.1
Raichlen, J.S.2
Cain, V.A.3
-
21
-
-
0033956848
-
Influence of triglyceride concentration on the relationship between lipoprotein cholesterol and apolipoprotein B and A-I levels
-
LeRoux G., Lemieux I., Lamarche B., Cantin B., Dagenais G.R., Lupien P.J., and Despres J.P. Influence of triglyceride concentration on the relationship between lipoprotein cholesterol and apolipoprotein B and A-I levels. Metabolism 49 (2000) 53-61
-
(2000)
Metabolism
, vol.49
, pp. 53-61
-
-
LeRoux, G.1
Lemieux, I.2
Lamarche, B.3
Cantin, B.4
Dagenais, G.R.5
Lupien, P.J.6
Despres, J.P.7
-
22
-
-
0034912018
-
Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality
-
Cui Y., Blumenthal R.S., Flaws J.A., Whiteman M.K., Langenberg P., Bachorik P.S., and Bush T.L. Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med 161 (2001) 1413-1419
-
(2001)
Arch Intern Med
, vol.161
, pp. 1413-1419
-
-
Cui, Y.1
Blumenthal, R.S.2
Flaws, J.A.3
Whiteman, M.K.4
Langenberg, P.5
Bachorik, P.S.6
Bush, T.L.7
-
23
-
-
13844272245
-
Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial)
-
Grundy S.M., Vega G.L., Yuan Z., Battisti W.P., Brady W.E., and Palmisano J. Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial). Am J Cardiol 95 (2005) 462-468
-
(2005)
Am J Cardiol
, vol.95
, pp. 462-468
-
-
Grundy, S.M.1
Vega, G.L.2
Yuan, Z.3
Battisti, W.P.4
Brady, W.E.5
Palmisano, J.6
-
24
-
-
0023461362
-
An international collaborative study on standardization of apolipoprotein A-I and apolipoprotein B: part I. Evaluation of a lyophilized candidate reference and calibration material
-
Smith S.J., Cooper G.R., Henderson L.O., and Hannon W.H. An international collaborative study on standardization of apolipoprotein A-I and apolipoprotein B: part I. Evaluation of a lyophilized candidate reference and calibration material. Clin Chem 33 (1987) 2240-2249
-
(1987)
Clin Chem
, vol.33
, pp. 2240-2249
-
-
Smith, S.J.1
Cooper, G.R.2
Henderson, L.O.3
Hannon, W.H.4
-
25
-
-
0022885505
-
Two new monoclonal antibody-based enzyme-linked assays of apolipoprotein B
-
Young S.G., Smith R.S., Hogle D.M., Curtiss L.K., and Witztum J.L. Two new monoclonal antibody-based enzyme-linked assays of apolipoprotein B. Clin Chem 32 (1986) 1484-1490
-
(1986)
Clin Chem
, vol.32
, pp. 1484-1490
-
-
Young, S.G.1
Smith, R.S.2
Hogle, D.M.3
Curtiss, L.K.4
Witztum, J.L.5
-
26
-
-
22244446183
-
Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women
-
Ridker P.M., Rifai N., Cook N.R., Bradwin G., and Buring J.E. Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA 294 (2005) 326-333
-
(2005)
JAMA
, vol.294
, pp. 326-333
-
-
Ridker, P.M.1
Rifai, N.2
Cook, N.R.3
Bradwin, G.4
Buring, J.E.5
-
27
-
-
38349057905
-
Non-HDL cholesterol and apoB in dyslipidaemia
-
Sniderman A.D., Hogue J.C., Bergeron J., Gagne C., and Couture P. Non-HDL cholesterol and apoB in dyslipidaemia. Clin Sci Lond 114 (2008) 149-155
-
(2008)
Clin Sci Lond
, vol.114
, pp. 149-155
-
-
Sniderman, A.D.1
Hogue, J.C.2
Bergeron, J.3
Gagne, C.4
Couture, P.5
-
28
-
-
0023850471
-
Comparison of commercial kits for apoprotein-A-I and apoprotein-B with standardized apoprotein-A-I and B radioimmunoassays performed at the Northwest Lipid Research Center
-
Albers J.J., and Adolphson J.L. Comparison of commercial kits for apoprotein-A-I and apoprotein-B with standardized apoprotein-A-I and B radioimmunoassays performed at the Northwest Lipid Research Center. J Lipid Res 29 (1988) 102-108
-
(1988)
J Lipid Res
, vol.29
, pp. 102-108
-
-
Albers, J.J.1
Adolphson, J.L.2
-
29
-
-
0033624053
-
Measurement of apolipoprotein B concentration in plasma lipoproteins by combining selective precipitation and mass spectrometry
-
Beghin L., Duhal N., Poulain P., Hauw P., Lacroix B., Lecerf J.M., Bonte J.P., Fruchart J.C., and Luc G. Measurement of apolipoprotein B concentration in plasma lipoproteins by combining selective precipitation and mass spectrometry. J Lipid Res 41 (2000) 1172-1176
-
(2000)
J Lipid Res
, vol.41
, pp. 1172-1176
-
-
Beghin, L.1
Duhal, N.2
Poulain, P.3
Hauw, P.4
Lacroix, B.5
Lecerf, J.M.6
Bonte, J.P.7
Fruchart, J.C.8
Luc, G.9
-
30
-
-
0028179990
-
International Federation of Clinical Chemistry standardization project for measurements of apolipoprotein-A-I and apolipoprotein-B. Part IV. Comparability of apolipoprotein-B values by use of international reference material
-
Marcovina S.M., Albers J.J., Kennedy H., Mei J.V., Henderson L.O., and Hannon W.H. International Federation of Clinical Chemistry standardization project for measurements of apolipoprotein-A-I and apolipoprotein-B. Part IV. Comparability of apolipoprotein-B values by use of international reference material. Clin Chem 40 (1994) 586-592
-
(1994)
Clin Chem
, vol.40
, pp. 586-592
-
-
Marcovina, S.M.1
Albers, J.J.2
Kennedy, H.3
Mei, J.V.4
Henderson, L.O.5
Hannon, W.H.6
|